Colchicine is an ancient medication that is currently approved for the treatment of gout and
FMF. However, colchicine has a wide range of anti-inflammatory activities, and studies …

Background: Gout is a common type of inflammatory arthritis in patients seen by primary
care physicians. Purpose: To review evidence about treatment of acute gout attacks …

Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …

[Background] Accumulated evidences suggested that hyperuricemia may be risk for renal
failures, cardiovascular disease and life-style related disease since the 2 nd edition of the …

Background This is an updated Cochrane Review, first published in 2006 and updated in
2014. Gout is one of the most common rheumatic diseases worldwide. Despite the use of …

Иммуновоспалительные заболевания (ИВЗ; immune-mediated inflammatory disease)
относятся к числу наиболее тяжелых хронических болезней человека. Ведущими …

8. Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da
Universidade de Lisboa 9. Rheumatology, Clínica Coração de Jesus, Lisboa prophylaxis; …

Objective. To systematically review the evidence on treatment available to prevent an acute
attack of gout when initiating a urate-lowering therapy (ULT) and for how long this treatment …

Objective. The aim of this study was to systematically review outcome domains and
measurement tools used in gout trials and their accordance with the preliminary OMERACT …

Для профилактики приступов артрита при подагре используют нестероидные
противовоспалительные препараты (НПВП), колхицин и глюкокортикоиды (ГК), однако …